Theriva Biologics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 255.73 K | $53.70 K | 1,461.02% | 2.11% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 212.09 K | $44.62 K | 651.84% | 1.75% |
| MORGAN STANLEY | 02/13/2026 | 200.00 K | $42.08 K | 100.00% | 1.65% |
| UBS GROUP AG | 01/29/2026 | 191.41 K | $40.20 K | 735.38% | 1.58% |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 112.08 K | $23.58 K | -6.63% | 0.92% |
| TWO SIGMA SECURITIES, LLC | 02/17/2026 | 42.89 K | $9.03 K | 100.00% | 0.35% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 42.34 K | $8.91 K | -31.53% | 0.35% |
| DRW SECURITIES, LLC | 02/12/2026 | 41.75 K | $8.78 K | 100.00% | 0.34% |
| XTX TOPCO LTD | 02/17/2026 | 39.45 K | $8.30 K | 19.90% | 0.32% |
| STONEX GROUP INC. | 02/12/2026 | 37.22 K | $7.83 K | 100.00% | 0.31% |
| BARCLAYS PLC | 02/13/2026 | 32.57 K | $6.85 K | 6,479.60% | 0.27% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 31.14 K | $6.54 K | 38,343.21% | 0.26% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 27.65 K | $5.82 K | -22.34% | 0.23% |
| SCHWARZ DYGOS WHEELER INVESTMENT ADVISORS LLC | 02/09/2026 | 15.00 K | $3.16 K | 100.00% | 0.12% |
| BLACKROCK, INC. | 02/12/2026 | 7.50 K | $1.58 K | -0.03% | 0.06% |
| CITIGROUP INC | 02/13/2026 | 6.19 K | $1.30 K | 100.00% | 0.05% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 448 | $93 | 0.90% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 59 | $12 | 0.00% | 0.00% |
| IFP ADVISORS, INC | 02/06/2026 | 11 | $2 | 0.00% | 0.00% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 01/21/2026 | 5 | $1 | 100.00% | 0.00% |
| HRT FINANCIAL LP | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/23/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
| WEALTHSPIRE ADVISORS, LLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| CLEAR STREET GROUP INC. | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
Theriva Biologics Inc institutional Ownership - FAQ's
During the previous two years, 29 institutional investors and hedge funds held shares of Theriva Biologics Inc. The most heavily invested institutionals were:
UBS Group AG: 225,624
SBI Securities Co., Ltd.: 131
IFP Advisors, Inc: 11
Newbridge Financial Services Group, Inc.: 5
VANGUARD GROUP INC: 255,727
GEODE CAPITAL MANAGEMENT, LLC: 212,087
10.67% of Theriva Biologics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 1.52 M shares in the last 24 months. This purchase volume represents approximately $273.43 K in transactions.